Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
October 31 2024 - 7:00AM
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company
specializing in highly effective, non-invasive treatments for both
oncological and non-oncological conditions, announces that
management will hold a conference call on Thursday, November 14,
2024 at 4:30 p.m. Eastern time to discuss the financial results for
the third quarter of 2024. In addition, management will provide a
business update and a discussion on recent and upcoming milestones.
Participants are encouraged to pre-register for
the conference call using this link. Upon registration participants
will receive a unique dial-in number that will permit them to
bypass the live operator. Participants may pre-register at any
time, including up to and after the call start time. Those without
internet access or unable to pre-register can access the
conference call by dialing 844-481-2811 (U.S. and Canada Toll Free)
or 412-317-0676 (International). Please direct the operator to be
connected to the Sensus Healthcare conference call.
The call will be webcast live and can be
accessed at this link, which also can be found in the Investor
Relations section of the Company’s website at
www.sensushealthcare.com.
Following the conclusion of the conference call,
a telephone replay will be available until December 14, 2024 and
can be accessed by dialing 877-344-7529 (U.S. Toll Free),
855-669-9658 (Canada Toll Free) or 412-317-0088 (International). At
the system prompt, enter the replay code 3932512 followed by the #
sign. An archived webcast of the call will also be available in the
Investor Relations section of the Company’s website for a period of
time.
About Sensus Healthcare,
Inc.
Sensus Healthcare, Inc. is a global pioneer in
the development and delivery of non-invasive treatments for skin
cancer and keloids. Leveraging its cutting-edge superficial
radiotherapy (SRT and IG-SRT) technology, the company provides
healthcare providers with a highly effective, patient-centric
treatment platform. With a dedication to driving innovation in
radiation oncology, Sensus Healthcare offers solutions that are
safe, precise, and adaptable to a variety of clinical settings. For
more information, please visit www.sensushealthcare.com.
Contact: Alliance Advisors IR Kim Sutton
Golodetz212-838-3777kgolodetz@allianceadvisors.com
# # #
Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Oct 2024 to Oct 2024
Sensus Healthcare (NASDAQ:SRTS)
Historical Stock Chart
From Oct 2023 to Oct 2024